Mr. Speaker, here is a cost-benefit analysis: 35% fewer overdose deaths.
Let me also say that the evidence shows, and not just from InSite but from other sites in Europe as well, that people who are using InSite and the services there are twice as likely to want to access the rehabilitation and treatment centres that we have to offer.
This aspect is an integral part of dealing with an issue that is of major concern. The government, at the very time it is cutting rehabilitation and support for substance abusers as well as for other people who need rehabilitation, then has the audacity to say that this is not an effective program when science tells us it is.